News | March 11, 2024
Briefs: Zydus Lifesciences and Rainbow Children's Medicare
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
The company will provide comprehensive response to USFDA for the observations
The investment will catalyse various components of the IndiaAI Mission
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
The Convocation ceremony was organized for students skilled and certified in Ayush
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
The production started from its greenfield manufacturing facility at Aurangabad in Maharashtra
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Subscribe To Our Newsletter & Stay Updated
